The new agreement will significantly improve access to and affordability of the R21/Matrix-M malaria vaccines, helping to protect more children from one of the world's deadliest diseases, according to UNICEF.
Breakdown
- UNICEF is working to reduce the cost of the R21/Matrix-M malaria vaccine.
- The vaccine's price will drop to nearly $3 per dose within about a year. 17s
- A Gavi-backed deal will generate over $90 million, enabling production of 30 million more doses and targeting 7 million additional children in the next five years. 23s
- Over 40 million malaria vaccine doses have been delivered through the Gavi programme and are now part of routine immunisation in 24 African countries. 41s
- In 2023, there were an estimated 263 million malaria cases and 597,000 deaths worldwide. 58s